Effect of combination therapy with recombinant thrombomodulin and antithrombin on outcomes in patients with sepsis-induced disseminated intravascular coagulation in a surgical intensive care unit: a retrospective observational study
Authors:
Open Access
- 19 September 2026
- journal article
- research article
- Published by Springer Nature in Journal of Anesthesia
- p. 1-11
Abstract
No abstract availableKeywords
Funding Information
- Nagoya University
This publication has 34 references indexed in Scilit:
- Efficacy of antithrombin administration for patients with sepsis: A systematic review, meta‐analysis, and meta‐regressionAcute Medicine & Surgery, 2024
- Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysisThrombosis Research, 2023
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudyThe Lancet, 2020
- Significance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline modelThrombosis Research, 2019
- Role of disseminated intravascular coagulation in severe sepsisThrombosis Research, 2019
- Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated CoagulopathyJAMA, 2019
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic ratsThrombosis Research, 2014
- The Purification and Mechanism of Action of Human Antithrombin-Heparin CofactorJournal of Biological Chemistry, 1973